Knee Injuries Completed Phase 3 Trials for Ropivacaine (DB00296)

Also known as: Knee Injury / Injuries, Knee / Injury, Knee / Joint injury

IndicationStatusPhase
DBCOND0031346 (Knee Injuries)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01971645Decadron as Adjuvant in Femoral Nerve Blocks in Knee ArthroscopyTreatment